Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > USA. M. MargetuxiMAb Inj. IV Use

---

USA. M. MargetuxiMAb Inj. IV Use's subsections
(*) USA Approval Date: 2020. 12.16
Company
TradeMark
TradeMark Web-Site

USA. M. MargetuxiMAb Inj. IV Use's products
This section has no products